Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to collect outcomes information to see what effects photon/proton beam radiation has on nasopharynx cancer.


Clinical Trial Description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00797290
Study type Observational
Source University of Florida
Contact
Status Terminated
Phase N/A
Start date June 2008
Completion date July 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05483374 - The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Active, not recruiting NCT03082534 - Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Phase 2
Completed NCT03096808 - Adaptive Radiotherapy for Head and Neck Cancer Phase 2
Not yet recruiting NCT04004871 - Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma Phase 2
Recruiting NCT06019130 - Nivolumab in Children and Adults With Nasopharyngeal Carcinoma Phase 2
Completed NCT03791944 - 3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma N/A